Going to Supply Side West? Stop by the BayMedica booth (#6531) to learn how adding rare cannabinoids to your products can help you differentiate from the competition, enhance your marketing segmentation, and increase your customer LTV!
BayMedica
生物技术研究
Incline Village,Nevada 488 位关注者
BayMedica leverages synthetic biology and chemistry to develop rare cannabinoids. A division of InMed Pharmaceuticals.
关于我们
BayMedica Inc., a division of InMed Pharmaceuticals (Nasdaq: INM) is a revenue-stage biotechnology company leveraging synthetic biology and pharmaceutical chemistry to develop an ef?cient, scalable, and proprietary platform to produce high quality, rare cannabinoids for consumer applications and cannabinoid-derived new chemical entities for pharmaceutical applications.
- 网站
-
https://www.baymedica.com
BayMedica的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Incline Village,Nevada
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Biosynthesis、Cannabinoids、Health & Wellness、Animal Health、Cosmetics、Pharmaceuticals和Nutraceuticals
地点
-
主要
930 Tahoe Blvd
US,Nevada,Incline Village,89451
BayMedica员工
动态
-
?? What’s fueling the explosive growth in the edibles market? It’s not what you think… ?? Consumers are willing to pay more for products that enhance their health and performance, and minor cannabinoids are emerging as the key ingredient that sets products apart. They’re catching the attention of a key demographic—35 to 54-year-olds—with more disposable income and are willing to invest in products that improve their performance. ?? The data shows that top edible brands now see up to 46% of their revenue from products with minor cannabinoids like CBN, THCV, and CBG. And this trend is set to spill over into other categories as brands look to stand out in the crowded wellness market. ?? ?? The takeaway for wellness and supplement brands? Investing in minor cannabinoids could be your key to capturing more value from health-conscious consumers and establishing leadership in this rapidly evolving space. ?? Check out The Dales Report’s full podcast episode in the comments below for deeper insights from two of the leading minor cannabinoid ingredient suppliers (BayMedica and FloraWorks) into how minor cannabinoids are reshaping the future of consumer wellness. #Cannabinoids #WellnessTrends #CPGIndustry #HealthAndWellness #CPG #Ingredients
-
?? Want to know where health and wellness CPG is heading? Ingredient suppliers are at the tip of the spear, living the leading indicators of where the market is moving. ?? One thing is clear: cannabinoids are poised to become as common as vitamins and supplements in homes nationwide within the next decade. ?? As we supply ingredients across the industry, we see a major trend—minor cannabinoids are no longer just for recreational and medicinal cannabis products. They’re finding a place in daily routines alongside nootropics and wellness supplements. However, regulatory clarity is essential to unlocking the full potential, especially for traditional CPG and VMS brands ready to dive in. ?? Check out the full podcast episode of The Dales Report in the comments below, featuring BayMedica’s VP of Sales & Marketing, Jerry Griffin, and FloraWorks’ VP of Sales & Marketing, Micah Hogan. #CPG #Cannabis #HealthandWellness
-
?? How does BayMedica transform common yeast into cannabinoid powerhouses? Our CEO, Dr. Shane Johnson, discusses the innovative process and its surprising parallels with everyday products like beer and vitamins. What’s the connection between large-scale vanilla production and scalable minor cannabinoid production? What are biosynthetic cannabinoids, and how are they made? The process is used in hundreds of products you likely consume every year. Want to understand the science without the jargon? Tune into this episode of The Dime Podcast! Check out the link to this full podcast episode in the first comment! ?? #Cannabinoids #Podcast #BayMedica #Ingredients #Cannabis #CPG
-
?? Confession Time What’s the most expensive lesson you’ve ever learned? Remember when CBD isolate cost $60k a kilo? ?? Dr. Shane Johnson shares a fascinating story on The Dime Podcast about his most expensive lessons, the unpredictable cannabinoid market, and the challenges of pricing in an ever-evolving landscape. Don't miss this eye-opening discussion that could change the way you think about cannabinoids and cannabis product development. Tune in now! Check out the link to this full podcast episode in the first comment! ?? #Cannabinoids #Podcast #BayMedica #NPD #Cannabis #CPG
-
?? Trend Alert! ?? Curious about which two minor cannabinoids are poised to revolutionize the market? Tune in as our CEO, Dr. Shane Johnson, delves into these two unsung minor cannabinoid heroes, generating buzz among cannabis product developers and wellness industry experts. Don't miss out on this insightful conversation on The Dime Podcast. ??? Check out the link to this full podcast episode in the first comment! ?? #Cannabinoids #Innovation #NPD #Podcast #BayMedica #CPG
-
?? Cannabinoid crystal ball time! ? What’s possible for the future of personalized medicine with cannabinoids? Imagine walking into your local wellness store with your genome on a chip and walking out with custom cannabinoid formulations tailored to your body’s specific needs to restore balance. We're not there yet, but the journey is underway. Our CEO, Dr. Shane Johnson, and The Dime Podcast’s Bryan and Kellen peer into the future of what’s possible for cannabinoids. ???? Curious about the future of cannabinoids and their potential to revolutionize health and wellness? Tune in to hear Dr. Johnson's fascinating predictions on this episode of The Dime Podcast. Check out the link to this full podcast episode in the first comment! ?? #Cannabinoids #PersonalizedMedicine #BayMedica #Cannabis #Wellness
-
?? Breaking Down Myths About Synthesized Ingredients Our CEO, Dr. Shane Johnson, dives into a topic that often sparks debate: synthesized cannabinoids "Many assume that synthesized means unnatural or harmful, but that's far from the truth. From the multivitamins we take to the caffeine in our drinks, synthesis is a part of our daily lives," says Shane. He emphasizes the importance of understanding and learning about these processes to dispel misinformation. Shane explains why synthesized ingredients can be purer and as safe as their natural counterparts. Let's challenge our assumptions, embrace informed choices and develop more consistent, stable products with the help of synthetic cannabinoids.? Check out the link to this full podcast episode in the first comment! ?? #Ingredients #CPG #Cannabinoids #Cannabis #Podcast?
-
?? New Podcast Alert!?? BayMedica’s very own Dr. Shane Johnson delves into the fascinating world of minor cannabinoids beyond THC and CBD on the Roots to Risk Podcast, highlighting their potential health benefits and biotech innovations. Learn more about the differentiation of effects between cannabinoids, the importance of consistent quality and the future of cannabinoid-based products in both consumer and pharmaceutical markets. ?? Tune in to gain insights into the biotech innovations at BayMedica and the future of cannabinoid-based products. Listen now. #Podcast #Cannabinoids #BayMedica #Biotech #HealthcareInnovation